Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

by Boylan, Kristin L. M., Misemer, Benjamin, DeRycke, Melissa S., Andersen, John D., Harrington, Katherine M., Kalloger, Steve E., Gilks, C. Blake, Pambuccian, Stefan E., Skubitz, Amy P. N.
Published 2011

Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes

by Milne, Katy, Alexander, Cheryl, Webb, John R, Sun, Winnie, Dillon, Kristy, Kalloger, Steve E, Gilks, C Blake, Clarke, Blaise, Köbel, Martin, Nelson, Brad H
Published 2012

Correction: Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

by Milne, Katy, Köbel, Martin, Kalloger, Steven E., Barnes, Rebecca O., Gao, Dongxia, Gilks, C. Blake, Watson, Peter H., Nelson, Brad H.
Published 2013

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

by Basile Tessier-Cloutier, Steve E. Kalloger, Mohammad Al-Kandari, Katy Milne, Dongxia Gao, Brad H. Nelson, Daniel J. Renouf, Brandon S. Sheffield, David F. Schaeffer
Published 2017-09-01

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

by Prentice, Leah M, Klausen, Christian, Kalloger, Steve, Köbel, Martin, McKinney, Steven, Santos, Jennifer L, Kenney, Challayne, Mehl, Erika, Gilks, C Blake, Leung, Peter, Swenerton, Ken, Huntsman, David G, Aparicio, Samuel AJ
Published 2007

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

by Anglesio, Michael S., Wiegand, Kimberly C., Melnyk, Nataliya, Chow, Christine, Salamanca, Clara, Prentice, Leah M., Senz, Janine, Yang, Winnie, Spillman, Monique A., Cochrane, Dawn R., Shumansky, Karey, Shah, Sohrab P., Kalloger, Steve E., Huntsman, David G.
Published 2013

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

by Anglesio, Michael S., Wiegand, Kimberly C., Melnyk, Nataliya, Chow, Christine, Salamanca, Clara, Prentice, Leah M., Senz, Janine, Yang, Winnie, Spillman, Monique A., Cochrane, Dawn R., Shumansky, Karey, Shah, Sohrab P., Kalloger, Steve E., Huntsman, David G.
Published 2013

Markers of T Cell Infiltration and Function Associate with Favorable Outcome in Vascularized High-Grade Serous Ovarian Carcinoma

by Townsend, Katelin N., Spowart, Jaeline E., Huwait, Hassan, Eshragh, Sima, West, Nathan R., Elrick, Mary A., Kalloger, Steve E., Anglesio, Michael, Watson, Peter H., Huntsman, David G., Lum, Julian J.
Published 2013

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and...

by Wiegand, Kimberly C, Hennessy, Bryan T, Leung, Samuel, Wang, Yemin, Ju, Zhenlin, McGahren, Mollianne, Kalloger, Steve E, Finlayson, Sarah, Stemke-Hale, Katherine, Lu, Yiling, Zhang, Fan, Anglesio, Michael S, Gilks, Blake, Mills, Gordon B, Huntsman, David G, Carey, Mark S
Published 2014

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

by Anglesio, Michael S., Wiegand, Kimberly C., Melnyk, Nataliya, Chow, Christine, Salamanca, Clara, Prentice, Leah M., Senz, Janine, Yang, Winnie, Spillman, Monique A., Cochrane, Dawn R., Shumansky, Karey, Shah, Sohrab P., Kalloger, Steve E., Huntsman, David G.
Published 2013

Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction

by Talhouk, Aline, Kommoss, Stefan, Mackenzie, Robertson, Cheung, Martin, Leung, Samuel, Chiu, Derek S., Kalloger, Steve E., Huntsman, David G., Chen, Stephanie, Intermaggio, Maria, Gronwald, Jacek, Chan, Fong C., Ramus, Susan J., Steidl, Christian, Scott, David W., Anglesio, Michael S.
Published 2016

HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer

by Mondal, Susmita, Roy, Debarshi, Camacho-Pereira, Juliana, Khurana, Ashwani, Chini, Eduardo, Yang, Lifeng, Baddour, Joelle, Stilles, Katherine, Padmabandu, Seth, Leung, Sam, Kalloger, Steve, Gilks, Blake, Lowe, Val, Dierks, Thomas, Hammond, Edward, Dredge, Keith, Nagrath, Deepak, Shridhar, Viji
Published 2015

Expression of Matrix Metalloproteinase-1 in Alveolar Macrophages, Type II Pneumocytes, and Airways in Smokers: Relationship to Lung Function and Emphysema

by Wallace, Alison M., Loy, Leanna B., Abboud, Raja T., D’Armiento, Jeanine M., Coxson, Harvey O., Muller, Nestor L., Kalloger, Steve, Li, Xing, Mark Elliott, W., English, John C., Finley, Richard J., Paré, Peter D.
Published 2014

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

by Press, Joshua Z, De Luca, Alessandro, Boyd, Niki, Young, Sean, Troussard, Armelle, Ridge, Yolanda, Kaurah, Pardeep, Kalloger, Steve E, Blood, Katherine A, Smith, Margaret, Spellman, Paul T, Wang, Yuker, Miller, Dianne M, Horsman, Doug, Faham, Malek, Gilks, C Blake, Gray, Joe, Huntsman, David G
Published 2008

Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling

by Bashashati, Ali, Ha, Gavin, Tone, Alicia, Ding, Jiarui, Prentice, Leah M, Roth, Andrew, Rosner, Jamie, Shumansky, Karey, Kalloger, Steve, Senz, Janine, Yang, Winnie, McConechy, Melissa, Melnyk, Nataliya, Anglesio, Michael, Luk, Margaret TY, Tse, Kane, Zeng, Thomas, Moore, Richard, Zhao, Yongjun, Marra, Marco A, Gilks, Blake, Yip, Stephen, Huntsman, David G, McAlpine, Jessica N, Shah, Sohrab P
Published 2013

Mutation of FOXL2 in granulosa-cell tumors of the ovary

by Shah, S., Köbel, M., Senz, J., Morin, R., Clarke, B., Wiegand, K., Leung, G., Zayed, A., Mehl, E., Kalloger, S., Sun, M., Giuliany, R., Yorida, E., Jones, S., Varhol, Richard, Swenerton, K., Miller, D., Clement, P., Crane, C., Madore, J., Provencher, D., Leung, P., DeFazio, A., Khattra, J., Turashvili, G., Zhao, Y., Zeng, T., Glover, J., Vanderhyden, B., Zhao, C., Parkinson, C., Jimenez-Linan, M., Bowtell, D., Mes-Masson, A., Brenton, J., Aparicio, S., Boyd, N., Hirst, M., Gilks, C., Marra, M., Huntsman, D.
Published 2009

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

by Luchini, Claudio, Veronese, Nicola, Solmi, Marco, Cho, Hanbyoul, Kim, Jae-Hoon, Chou, Angela, Gill, Anthony J., Faraj, Sheila F., Chaux, Alcides, Netto, George J., Nakayama, Kentaro, Kyo, Satoru, Lee, Soo Young, Kim, Duck-Woo, Yousef, George M., Scorilas, Andreas, Nelson, Gregg S., Köbel, Martin, Kalloger, Steve E., Schaeffer, David F., Yan, Hai-Bo, Liu, Feng, Yokoyama, Yoshihito, Zhang, Xianyu, Pang, Da, Lichner, Zsuzsanna, Sergi, Giuseppe, Manzato, Enzo, Capelli, Paola, Wood, Laura D., Scarpa, Aldo, Correll, Christoph U.
Published 2015